|
Abbott Laboratories (ABT) |
|
|
|
ABT's Revenue Growth by Quarter and Year
Abbott Laboratories's Revenue results by quarter and year
Select the Comparisons :
|
|
Select the Ratio:
|
|
ABT Revenue (in millions $) |
FY 2024 |
FY 2023 |
FY 2022 |
FY 2021 |
IV Quarter |
December |
-
|
10,241.00
|
10,091.00
|
11,468.00
|
III Quarter |
September |
10,635.00
|
10,143.00
|
10,410.00
|
10,928.00
|
II Quarter |
June |
10,377.00
|
9,978.00
|
11,257.00
|
10,223.00
|
I Quarter |
March |
9,964.00
|
9,747.00
|
11,895.00
|
10,456.00
|
FY |
|
30,976.00
|
40,109.00
|
43,653.00
|
43,075.00
|
ABT Revenue third quarter 2024 Y/Y Growth Comment |
Abbott Laboratories reported Revenue growth of 4.85% year on year in the third quarter 2024, to $ 10,635.00 millions, this is lower than Abbott Laboratories's recent average Revenue growth of 5.29%.
Looking into third quarter 2024 results within Major Pharmaceutical Preparations industry 56 other companies have achieved higher Revenue growth. While Abbott Laboratories' s Revenue increase of 4.85% ranks overall at the positon no. 886 in the third quarter 2024.
|
ABT Revenue ( Y/Y Growth %) |
2024
|
2023 |
2022 |
2021 |
IV Quarter |
December |
- |
1.49 % |
-12.01 % |
7.17 % |
III Quarter |
September |
4.85 % |
-2.56 % |
-4.74 % |
23.44 % |
II Quarter |
June |
4 % |
-11.36 % |
10.11 % |
39.51 % |
I Quarter |
March |
2.23 % |
-18.06 % |
13.76 % |
35.34 % |
FY |
|
- |
-8.12 % |
1.34 % |
24.47 % |
ABT Revenue (Quarter on Quarter Growth %) |
2024
|
2023 |
2022 |
2021 |
IV Quarter |
December |
- |
0.97 % |
-3.06 % |
4.94 % |
III Quarter |
September |
2.49 % |
1.65 % |
-7.52 % |
6.9 % |
II Quarter |
June |
4.14 % |
2.37 % |
-5.36 % |
-2.23 % |
I Quarter |
March |
-2.7 % |
-3.41 % |
3.72 % |
-2.29 % |
FY (Year on Year) |
|
- |
-8.12 % |
1.34 % |
24.47 % |
Revenue Y/Y Growth Statistics |
High |
Average |
Low |
42.3 % |
5.29 % |
-47.82 % |
(Dec 31 2017) |
|
(Dec 31 2013) |
|
Revenue Y/Y Growth Statistics |
High |
Average |
Low |
42.3 % |
5.29 % |
-47.82 % |
(Dec 31 2017) |
|
(Dec 31 2013) |
|
Revenue by Quarter for the Fiscal Years 2021, 2022, 2023, 2024 |
Abbott Laboratories's Q/Q Revenue Growth
Revenue Q/Q Growth Statistics |
High |
Average |
Low |
85.61 % |
1.87 % |
-50.37 % |
(June 30. 2012) |
|
|
ABT's III. Quarter Q/Q Revenue Comment |
Abbott Laboratories achieved in the III. Quarter 2024 above company average sequential Revenue growth of 2.49%, to $ 10,635.00 millions, from $10,377.00 millions in the second quarter.
Within Major Pharmaceutical Preparations industry 17 other companies have achieved higher Revenue quarter on quarter growth. While Abbott Laboratories's Revenue growth quarter on quarter, overall rank is 339. |
|
|
Revenue Q/Q Growth Statistics |
High |
Average |
Low |
85.61 % |
1.87 % |
-50.37 % |
(June 30. 2012) |
|
|
ABT's III. Quarter Q/Q Revenue Comment |
Abbott Laboratories achieved in the III. Quarter 2024 above company average sequential Revenue growth of 2.49%, to $ 10,635.00 millions, from $10,377.00 millions in the second quarter.
Within Major Pharmaceutical Preparations industry 17 other companies have achieved higher Revenue quarter on quarter growth. While Abbott Laboratories's Revenue growth quarter on quarter, overall rank is 339. |
|
Abbott Laboratories's 12 Months Revenue Growth Year on Year
Revenue TTM Growth |
12 Months Ending (Sep 30 2024) |
12 Months Ending (Jun 30 2024) |
12 Months Ending (Mar 31 2024) |
12 Months Ending (Dec 31 2023) |
12 Months Ending (Sep 30 2023) |
Cumulative Revenue 12 Months Ending |
$ 41,217.00 |
$ 40,725.00 |
$ 40,326.00 |
$ 40,109.00 |
$ 39,959.00 |
Y / Y Revenue Growth (TTM) |
3.15 % |
1.24 % |
-2.84 % |
-8.12 % |
-11.26 % |
Year on Year Revenue Growth Overall
Ranking |
# 757 |
# 832 |
# 1556 |
# 1171 |
# 664 |
Seqeuential Revenue Change (TTM) |
1.21 % |
0.99 % |
0.54 % |
0.38 % |
-0.66 % |
Seq. Revenue Growth (TTM) Overall
Ranking |
# 568 |
# 1894 |
# 780 |
# 1390 |
# 643 |
Cumulative Revenue growth
Comment |
Although Abbott Laboratories's Annual Revenue growth year on year were below company's average 5.01% , Revenue announced in the Sep 30 2024 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 3.15% year on year, from 1.24% in Jun 30 2024.
In the Healthcare sector 75 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 757, from total ranking in previous quarter at 832. |
Revenue TTM Q/Q Growth Statistics |
High |
Average |
Low |
31.35 % |
5.01 % |
-39.34 % |
|
|
|
|
|
Revenue TTM Y/Y Growth Statistics |
High |
Average |
Low |
31.35 % |
5.01 % |
-39.34 % |
|
|
|
Revenue TTM Q/Q Growth Company Ranking |
Within: |
No. |
Industry |
# 20 |
Sector |
# 67 |
S&P 500 |
# 568 |
|
Cumulative Revenue growth
Comment |
Although Abbott Laboratories's Annual Revenue growth year on year were below company's average 5.01% , Revenue announced in the Sep 30 2024 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 3.15% year on year, from 1.24% in Jun 30 2024.
In the Healthcare sector 75 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 757, from total ranking in previous quarter at 832. |
Revenue TTM Q/Q Growth Statistics |
High |
Average |
Low |
31.35 % |
5.01 % |
-39.34 % |
|
|
|
Revenue TTM Y/Y Growth Statistics |
High |
Average |
Low |
31.35 % |
5.01 % |
-39.34 % |
|
|
|
Revenue TTM Q/Q Growth Company Ranking |
Within: |
No. |
Industry |
# 20 |
Sector |
# 67 |
S&P 500 |
# 568 |
|